VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Thursday, January 1, 2026

Stock Comparison

ABB Ltd vs Bio-Rad Laboratories, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

ABB Ltd

ABBN · SIX Swiss Exchange

Market cap (USD)$136.3B
SectorIndustrials
CountryCH
Data as of2025-12-31
Moat score
73/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into ABB Ltd's moat claims, evidence, and risks.

View ABBN analysis

Bio-Rad Laboratories, Inc.

BIO · New York Stock Exchange

Market cap (USD)
SectorHealthcare
CountryUS
Data as of2025-12-30
Moat score
61/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Bio-Rad Laboratories, Inc.'s moat claims, evidence, and risks.

View BIO analysis

Comparison highlights

  • Moat score gap: ABB Ltd leads (73 / 100 vs 61 / 100 for Bio-Rad Laboratories, Inc.).
  • Segment focus: ABB Ltd has 4 segments (46.2% in Electrification); Bio-Rad Laboratories, Inc. has 2 segments (59.9% in Clinical Diagnostics).
  • Moat breadth: ABB Ltd has 6 moat types across 3 domains; Bio-Rad Laboratories, Inc. has 6 across 3.

Primary market context

ABB Ltd

Electrification

Market

Low- and medium-voltage electrification equipment and solutions

Geography

Global

Customer

B2B/B2G

Role

Manufacturer and solutions provider; channel-led distribution; after-sales service

Revenue share

46.2%

Bio-Rad Laboratories, Inc.

Clinical Diagnostics

Market

In vitro diagnostics test systems, reagents/test kits, informatics, and clinical laboratory quality controls

Geography

Global

Customer

Hospital laboratories; diagnostic reference laboratories; transfusion laboratories; physician office laboratories

Role

IVD OEM / installed-base consumables supplier (systems + kits + controls)

Revenue share

59.9%

Side-by-side metrics

ABB Ltd
Bio-Rad Laboratories, Inc.
Ticker / Exchange
ABBN - SIX Swiss Exchange
BIO - New York Stock Exchange
Market cap (USD)
$136.3B
n/a
Sector
Industrials
Healthcare
HQ country
CH
US
Primary segment
Electrification
Clinical Diagnostics
Market structure
Oligopoly
Oligopoly
Market share
n/a
9%-11% (implied)
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
73 / 100
61 / 100
Moat domains
Supply, Demand, Network
Supply, Demand, Legal
Last update
2025-12-31
2025-12-30

Moat coverage

Shared moat types

Distribution ControlInstalled Base Consumables

ABB Ltd strengths

Brand TrustService Field NetworkData Workflow LockinEcosystem Complements

Bio-Rad Laboratories, Inc. strengths

Scope EconomiesCapex Knowhow ScaleSwitching Costs GeneralCompliance Advantage

Segment mix

ABB Ltd segments

Full profile >

Electrification

Oligopoly

46.2%

Motion

Oligopoly

22%

Process Automation

Oligopoly

20.5%

Robotics & Discrete Automation

Oligopoly

9.8%

Bio-Rad Laboratories, Inc. segments

Full profile >

Life Science

Competitive

40.1%

Clinical Diagnostics

Oligopoly

59.9%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.